Literature DB >> 27775796

Th17 cells associated cytokines and cancer.

S Feng1, X M Chen, J F Wang, X Q Xu.   

Abstract

Cancer is one of the most common malignant tumors, which is a serious threat to human life. However, the etiology of cancer is not entirely clear. Under the action of tumorigenic factors, tissue cells lose normal regulation, resulting in abnormal proliferation and differentiation, so as to form a tumor. Cytokines promote the development of chronic inflammation, which may affect the development of cancer, and Th17 cells are a kind of immune cells which are closely related to the tumor. Therefore, this article focused on the role of Th17 cells and its related cytokines in tumor, which is very important for understanding the mechanism of tumor development. This will provide a direction for immunotherapy and gene-targeted therapy of cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27775796

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  Detection of Treg/Th17 cells and related cytokines in peripheral blood of chronic hepatitis B patients combined with thrombocytopenia and the clinical significance.

Authors:  Yinghui Wang; Liru Wang; Wei Gao; Xi Chen; Yanhua Su
Journal:  Exp Ther Med       Date:  2018-06-14       Impact factor: 2.447

Review 2.  Th17 cells and inflammation in neurological disorders: Possible mechanisms of action.

Authors:  Yajun Shi; Bin Wei; Lingjun Li; Bin Wang; Miao Sun
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

3.  Inflammation and tumor progression: signaling pathways and targeted intervention.

Authors:  Huakan Zhao; Lei Wu; Guifang Yan; Yu Chen; Mingyue Zhou; Yongzhong Wu; Yongsheng Li
Journal:  Signal Transduct Target Ther       Date:  2021-07-12

4.  IFN-γ+ IL-17+ Th17 cells regulate fibrosis through secreting IL-21 in systemic scleroderma.

Authors:  Xiaojing Xing; Anqi Li; Hong Tan; Yong Zhou
Journal:  J Cell Mol Med       Date:  2020-11-06       Impact factor: 5.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.